© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 8, 618-629,
April 18, 2001
© 2001 Oxford University Press
Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study
Affiliations of authors: J. P. Neglia, A. C. Mertens, L. L. Robison, Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis; D. L. Friedman, Department of Pediatrics, University of Washington School of Medicine, and Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle; Y. Yasui, Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center; S. Hammond, Department of Pathology, Ohio State University School of Medicine, Columbus; M. Stovall, The University of Texas M. D. Anderson Cancer Center, Houston; S. S. Donaldson, Department of Radiation Oncology, Stanford University Medical Center, Palo Alto, CA; A. T. Meadows, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia.
Correspondence to: Joseph P. Neglia, M.D., M.P.H., MMC #484, 420 Delaware St., S.E., Minneapolis, MN 55455 (e-mail: jneglia{at}tc.umn.edu).
Background: Because survival rates among childhood cancer patients are increasing, assessing the risk of second and subsequent malignant neoplasms (SMNs) is ever more important. Using the Childhood Cancer Survivor Study cohort, we identified the risk of SMNs. Methods: A retrospective cohort of 13 581 children diagnosed with common cancers before age 21 years and surviving at least 5 years was constructed with the use of data from patients treated at 25 U.S. and Canadian institutions. SMNs were ascertained through self-administered questionnaires and verified by pathology reports. Information on therapeutic exposures was abstracted from medical records. The risk of SMN was evaluated by standardized incidence ratios (SIRs) and excess absolute risk. Poisson multiple regression models were used to assess the impact of host and therapy factors on the risk of developing SMNs. All statistical tests were two-sided. Results: In 298 individuals, 314 SMNs were identified (SIR = 6.38; 95% confidence interval [CI] = 5.69 to 7.13). The largest observed excess SMNs were bone and breast cancers (SIR = 19.14 [95% CI = 12.72 to 27.67] and SIR = 16.18 [95% CI = 12.35 to 20.83], respectively). A statistically significant excess of SMNs followed all childhood cancers. In multivariate regression models adjusted for therapeutic radiation exposure, SMNs of any type were independently associated with female sex (P<.001), childhood cancer at a younger age (P for trend <.001), childhood Hodgkin's disease or soft-tissue sarcoma (P<.001 and P = .01, respectively), and exposure to alkylating agents (P for trend = .02). Twenty years after the childhood cancer diagnosis, the cumulative estimated SMN incidence was 3.2%. However, only 1.88 excess malignancies occurred per 1000 years of patient follow-up. Conclusions: Success in treating children with cancer should not be overshadowed by the incidence of SMNs. However, patients and health-care providers must be aware of risk factors for SMNs so that surveillance is focused and early prevention strategies are implemented.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Mody, S. Li, D. C. Dover, S. Sallan, W. Leisenring, K. C. Oeffinger, Y. Yasui, L. L. Robison, and J. P. Neglia Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study Blood, June 15, 2008; 111(12): 5515 - 5523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Bluhm, C. Ronckers, R. J. Hayashi, J. P. Neglia, A. C. Mertens, M. Stovall, A. T. Meadows, P. A. Mitby, J. A. Whitton, S. Hammond, et al. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study Blood, April 15, 2008; 111(8): 4014 - 4021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. Barry, L. M. Vrooman, S. E. Dahlberg, D. S. Neuberg, B. L. Asselin, U. H. Athale, L. A. Clavell, E. C. Larsen, A. Moghrabi, Y. Samson, et al. Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane J. Clin. Oncol., March 1, 2008; 26(7): 1106 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Schneider, E. Ron, J. Lubin, M. Stovall, E. Shore-Freedman, J. Tolentino, and B. J. Collins Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck Neuro-oncol, February 1, 2008; 10(1): 73 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Friedman, A. Rovo, W. Leisenring, A. Locasciulli, M. E. D. Flowers, A. Tichelli, J. E. Sanders, H. J. Deeg, and G. Socie Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party Blood, January 15, 2008; 111(2): 939 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T. Armstrong, C. A. Sklar, M. M. Hudson, and L. L. Robison Long-Term Health Status Among Survivors of Childhood Cancer: Does Sex Matter? J. Clin. Oncol., October 1, 2007; 25(28): 4477 - 4489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Stochholm, C. H. Gravholt, T. Laursen, P. Laurberg, M. Andersen, L. O. Kristensen, U. Feldt-Rasmussen, J. S. Christiansen, M. Frydenberg, and A. Green Mortality and GH deficiency: a nationwide study Eur. J. Endocrinol., July 1, 2007; 157(1): 9 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Guerin, M. Hawkins, A. Shamsaldin, C. Guibout, I. Diallo, O. Oberlin, L. Brugieres, and F. de Vathaire Treatment-Adjusted Predisposition to Second Malignant Neoplasms After a Solid Cancer in Childhood: A Case-Control Study J. Clin. Oncol., July 1, 2007; 25(19): 2833 - 2839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Geenen, M. C. Cardous-Ubbink, L. C. M. Kremer, C. van den Bos, H. J. H. van der Pal, R. C. Heinen, M. W. M. Jaspers, C. C. E. Koning, F. Oldenburger, N. E. Langeveld, et al. Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer JAMA, June 27, 2007; 297(24): 2705 - 2715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maule, G. Scelo, G. Pastore, P. Brennan, K. Hemminki, E. Tracey, R. Sankila, E. Weiderpass, J. H. Olsen, M. L. McBride, et al. Risk of Second Malignant Neoplasms After Childhood Leukemia and Lymphoma: An International Study J Natl Cancer Inst, May 16, 2007; 99(10): 790 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hijiya, M. M. Hudson, S. Lensing, M. Zacher, M. Onciu, F. G. Behm, B. I. Razzouk, R. C. Ribeiro, J. E. Rubnitz, J. T. Sandlund, et al. Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia JAMA, March 21, 2007; 297(11): 1207 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Krishnan and G. J. Morgan Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 377 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Dickerman The Late Effects of Childhood Cancer Therapy Pediatrics, March 1, 2007; 119(3): 554 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Skinner, W H. B Wallace, and G. Levitt Long-term follow-up of children treated for cancer: why is it necessary, by whom, where and how? Arch. Dis. Child., March 1, 2007; 92(3): 257 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. O. Henderson, J. Whitton, M. Stovall, A. C. Mertens, P. Mitby, D. Friedman, L. C. Strong, S. Hammond, J. P. Neglia, A. T. Meadows, et al. Secondary Sarcomas in Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study J Natl Cancer Inst, February 21, 2007; 99(4): 300 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Tebbi, W. B. London, D. Friedman, D. Villaluna, P. A. De Alarcon, L. S. Constine, N. P. Mendenhall, R. Sposto, A. Chauvenet, and C. L. Schwartz Dexrazoxane-Associated Risk for Acute Myeloid Leukemia/Myelodysplastic Syndrome and Other Secondary Malignancies in Pediatric Hodgkin's Disease J. Clin. Oncol., February 10, 2007; 25(5): 493 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kleinerman, M. A. Tucker, D. H. Abramson, J. M. Seddon, R. E. Tarone, and J. F. Fraumeni Jr Risk of Soft Tissue Sarcomas by Individual Subtype in Survivors of Hereditary Retinoblastoma J Natl Cancer Inst, January 3, 2007; 99(1): 24 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Bowers, Y. Liu, W. Leisenring, E. McNeil, M. Stovall, J. G. Gurney, L. L. Robison, R. J. Packer, and K. C. Oeffinger Late-Occurring Stroke Among Long-Term Survivors of Childhood Leukemia and Brain Tumors: A Report From the Childhood Cancer Survivor Study J. Clin. Oncol., November 20, 2006; 24(33): 5277 - 5282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ron Childhood cancer--treatment at a cost. J Natl Cancer Inst, November 1, 2006; 98(21): 1510 - 1511. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Neglia, L. L. Robison, M. Stovall, Y. Liu, R. J. Packer, S. Hammond, Y. Yasui, C. E. Kasper, A. C. Mertens, S. S. Donaldson, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst, November 1, 2006; 98(21): 1528 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Oeffinger, A. C. Mertens, C. A. Sklar, T. Kawashima, M. M. Hudson, A. T. Meadows, D. L. Friedman, N. Marina, W. Hobbie, N. S. Kadan-Lottick, et al. Chronic Health Conditions in Adult Survivors of Childhood Cancer. N. Engl. J. Med., October 12, 2006; 355(15): 1572 - 1582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Kendall, P. M. Vacek, J. L. Rivers, S. C. Rice, T. L. Messier, and B. A. Finette Analysis of Genetic Alterations and Clonal Proliferation in Children Treated for Acute Lymphocytic Leukemia. Cancer Res., September 1, 2006; 66(17): 8455 - 8461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Sklar, A. C. Mertens, P. Mitby, J. Whitton, M. Stovall, C. Kasper, J. Mulder, D. Green, H. S. Nicholson, Y. Yasui, et al. Premature Menopause in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Natl Cancer Inst, July 5, 2006; 98(13): 890 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Meck, M. Leary, and R. H. Sills Late Effects in Survivors of Childhood Cancer Pediatr. Rev., July 1, 2006; 27(7): 257 - 263. [Full Text] [PDF]
|
|
|
|
 |
|
 D G R Evans, J M Birch, R T Ramsden, S Sharif, and M E Baser Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes J. Med. Genet., April 1, 2006; 43(4): 289 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Leisenring, D. L. Friedman, M. E.D. Flowers, J. L. Schwartz, and H. J. Deeg Nonmelanoma Skin and Mucosal Cancers After Hematopoietic Cell Transplantation J. Clin. Oncol., March 1, 2006; 24(7): 1119 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bassal, A. C. Mertens, L. Taylor, J. P. Neglia, B. S. Greffe, S. Hammond, C. M. Ronckers, D. L. Friedman, M. Stovall, Y. Y. Yasui, et al. Risk of Selected Subsequent Carcinomas in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study J. Clin. Oncol., January 20, 2006; 24(3): 476 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Park, F. P. Li, Y. Liu, K. M. Emmons, A. Ablin, L. L. Robison, and A. C. Mertens Health Insurance Coverage in Survivors of Childhood Cancer: The Childhood Cancer Survivor Study J. Clin. Oncol., December 20, 2005; 23(36): 9187 - 9197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Perkins, Y. Liu, P. A. Mitby, J. P. Neglia, S. Hammond, M. Stovall, A. T. Meadows, R. Hutchinson, Z. E. Dreyer, L. L. Robison, et al. Nonmelanoma Skin Cancer in Survivors of Childhood and Adolescent Cancer: A Report From the Childhood Cancer Survivor Study J. Clin. Oncol., June 1, 2005; 23(16): 3733 - 3741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Guibout, E. Adjadj, C. Rubino, A. Shamsaldin, E. Grimaud, M. Hawkins, M.-C. Mathieu, O. Oberlin, J.-M. Zucker, X. Panis, et al. Malignant Breast Tumors After Radiotherapy for a First Cancer During Childhood J. Clin. Oncol., January 1, 2005; 23(1): 197 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bhatia Cancer Survivorship--Pediatric Issues Hematology, January 1, 2005; 2005(1): 507 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Landier, S. Bhatia, D. A. Eshelman, K. J. Forte, T. Sweeney, A. L. Hester, J. Darling, F. D. Armstrong, J. Blatt, L. S. Constine, et al. Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline J. Clin. Oncol., December 15, 2004; 22(24): 4979 - 4990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Kenney, Y. Yasui, P. D. Inskip, S. Hammond, J. P. Neglia, A. C. Mertens, A. T. Meadows, D. Friedman, L. L. Robison, and L. Diller Breast Cancer after Childhood Cancer: A Report from the Childhood Cancer Survivor Study Ann Intern Med, October 19, 2004; 141(8): 590 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Eshelman, W. Landier, T. Sweeney, A. L. Hester, K. Forte, J. Darling, and M. M. Hudson Facilitating Care for Childhood Cancer Survivors: Integrating Children's Oncology Group Long-Term Follow-Up Guidelines and Health Links in Clinical Practice Journal of Pediatric Oncology Nursing, September 1, 2004; 21(5): 271 - 280. [Abstract] [PDF]
|
|
|
|
 |
|
 K. C. Oeffinger and M. M. Hudson Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors CA Cancer J Clin, July 1, 2004; 54(4): 208 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Rice, P. Vacek, A. H. Homans, T. Messier, J. Rivers, H. Kendall, and B. A. Finette Genotoxicity of Therapeutic Intervention in Children with Acute Lymphocytic Leukemia Cancer Res., July 1, 2004; 64(13): 4464 - 4471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Smith and M. L. Hare An Overview of Progress in Childhood Cancer Survival Journal of Pediatric Oncology Nursing, May 1, 2004; 21(3): 160 - 164. [Abstract] [PDF]
|
|
|
|
|
|
D. M. Green The Treatment of Stages I-IV Favorable Histology Wilms' Tumor J. Clin. Oncol., April 15, 2004; 22(8): 1366 - 1372. [Full Text] [PDF]
|
|
|
|
|
|
S. Bhatia, Y. Yasui, L. L. Robison, J. M. Birch, M. K. Bogue, L. Diller, C. DeLaat, F. Fossati-Bellani, E. Morgan, O. Oberlin, et al. High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin's Disease: Report From the Late Effects Study Group J. Clin. Oncol., December 1, 2003; 21(23): 4386 - 4394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yasui, Y. Liu, J. P. Neglia, D. L. Friedman, S. Bhatia, A. T. Meadows, L. R. Diller, A. C. Mertens, J. Whitton, and L. L. Robison A Methodological Issue in the Analysis of Second-Primary Cancer Incidence in Long-Term Survivors of Childhood Cancers Am. J. Epidemiol., December 1, 2003; 158(11): 1108 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Berkow and L. L. Robison Childhood Cancer Survivor Study explores long-term outcomes AAP News, August 1, 2003; 23(2): 62 - 62. [Full Text] [PDF]
|
|
|
|
|
|
L. B. Travis, D. A. Hill, G. M. Dores, M. Gospodarowicz, F. E. van Leeuwen, E. Holowaty, B. Glimelius, M. Andersson, T. Wiklund, C. F. Lynch, et al. Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease JAMA, July 23, 2003; 290(4): 465 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. van Leeuwen, W. J. Klokman, M. Stovall, E. C. Dahler, M. B. van't Veer, E. M. Noordijk, M. A. Crommelin, B. M. P. Aleman, A. Broeks, M. Gospodarowicz, et al. Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease J Natl Cancer Inst, July 2, 2003; 95(13): 971 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Rosenberg, M. H. Greene, and B. P. Alter Cancer incidence in persons with Fanconi anemia Blood, February 1, 2003; 101(3): 822 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Emmons, R. M. Butterfield, E. Puleo, E. R. Park, A. Mertens, E. R. Gritz, M. Lahti, and F. P. Li Smoking Among Participants in the Childhood Cancer Survivors Cohort: The Partnership for Health Study J. Clin. Oncol., January 15, 2003; 21(2): 189 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Oberlin When Quality of Life Is the Major Challenge J. Clin. Oncol., July 15, 2002; 20(14): 3051 - 3053. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Sklar, A. C. Mertens, P. Mitby, G. Occhiogrosso, J. Qin, G. Heller, Y. Yasui, and L. L. Robison Risk of Disease Recurrence and Second Neoplasms in Survivors of Childhood Cancer Treated with Growth Hormone: A Report from the Childhood Cancer Survivor Study J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3136 - 3141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bhatia, H. N. Sather, O. B. Pabustan, M. E. Trigg, P. S. Gaynon, and L. L. Robison Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983 Blood, May 29, 2002; 99(12): 4257 - 4264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Kadan-Lottick, L. L. Robison, J. G. Gurney, J. P. Neglia, Y. Yasui, R. Hayashi, M. Hudson, M. Greenberg, and A. C. Mertens Childhood Cancer Survivors' Knowledge About Their Past Diagnosis and Treatment: Childhood Cancer Survivor Study JAMA, April 10, 2002; 287(14): 1832 - 1839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Vaughn and A. T. Meadows Cancer Survivorship Research: The Best Is Yet to Come J. Clin. Oncol., February 15, 2002; 20(4): 888 - 890. [Full Text] [PDF]
|
|
|
|
|
|
A. C. Mertens, Y. Yasui, J. P. Neglia, J. D. Potter, M. E. Nesbit Jr, K. Ruccione, W. Anthony Smithson, and L. L. Robison Late Mortality Experience in Five-Year Survivors of Childhood and Adolescent Cancer: The Childhood Cancer Survivor Study J. Clin. Oncol., July 1, 2001; 19(13): 3163 - 3172. [Abstract] [Full Text] [PDF]
|
|